Skip to content

Baduanjin Versus Brisk Walking for Cognition in Schizophrenia

Mindful Exercise Baduanjin Versus Brisk Walking for Cognitive Function in Patients With Schizophrenia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06226779
Enrollment
63
Registered
2024-01-26
Start date
2024-01-16
Completion date
2025-01-15
Last updated
2025-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, Exercise, Condition

Keywords

schizophrenia, mindful exercise, exercise, cognition

Brief summary

The current study intends to recruit participants with schizophrenia for the practice of Baduanjin, brisk walking, and health education after enrollment. The study also including a maintenance program. Cognitive and physical function assessments will be conducted before, after, and during follow-up tests. The research hypothesis posits that both Baduanjin and brisk walking will confer beneficial effects on various aspects of cognitive and physical functions.

Detailed description

Cognitive function deficits are core features in patients with schizophrenia. These deficits need active intervention to prevent functional decline. Baduanjin and brisk walking show promise as interventions in patients with schizophrenia. This study investigated the effects of Baduanjin exercise versus brisk walking in patients with schizophrenia. This study will be a single-blind, 3-arm, parallel, randomized controlled trial. A total of 72 patients with schizophrenia will be enrolled and randomly assigned to the Baduanjin group, brisk walking group or control group. The intervention group will practice Badunjin exercise. While participants in brisk walking group will receive brisk walking at the same duration. The controls will watch videos that are not aimed at improving physical exertion. Maintenance programs will also be conducted for participants to encourage practicing in exercise after intervention. All group will undergo evaluation at three time points: baseline, immediately after intervention and 4-week follow up after intervention. The primary outcome will be cognitive function and physical function. Secondary outcomes will include mood, sleep quality, and quality of live.

Interventions

BEHAVIORALBaduanjin exercsie

The Baduanjin exercise consists of 8 postures, with emphasis on different body parts. The exercise is commonly practiced as follows: (1) 2 hands holding up the heavens, (2) drawing the bow to shoot the eagle, (3) separating the heaven and earth, (4) wise owl gazing backwards, (5) swaying the head and shaking the tail, (6) 2 hands holding the feet to strengthen the waist, (7) clenching the fists and glaring fiercely, and (8) bouncing on the toes.

BEHAVIORALBrisk walking

The brisk walking will be gradually increased physical exertion from light to moderate of intensity. During the training period, the heart rate of participants will be monitored.

BEHAVIORALHealth education

Health education will include lecture classes. Video watching will watch videos which were not aim at improving physical exertion, such as sports games or sports related variety shows

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Having a diagnosis of schizophrenia according to the DSM-5. 2. Who will be above 20-65 years of age . 3. Having a stable mental status without shift in medication and keep in same dose for at least one month. 4. Being able to walk independently for 50 meters.

Exclusion criteria

1. Serious physical conditions that will impede participation, such as cardiovascular disease, musculoskeletal disease or pulmonary system disease. 2. Visual or auditory impairment that precludes completion of assessment. 3. Acute psychosis requiring hospitalization. 4. Presence of severe withdrawal or profound cognitive disability that cause difficulties in following instructions.

Design outcomes

Primary

MeasureTime frameDescription
Change scores of dual task Timed up-and-go test (cognitive)Baseline, immediate after treatment, 4-week follow upThis test combine serial three counting and Timed up-and-go test simultaneously. It evaluates dual task performance.
Change scores of Timed up-and-go testBaseline, immediate after treatment, 4-week follow upThis test evaluates functional mobility, agility and balance
Change scores of dual task Timed up-and-go test (manual)Baseline, immediate after treatment, 4-week follow upThis test requires carry a cup of water 3 cm from the top of the cup while performing the Timed up-and-go test. It evaluates dual task performance.
Change score of the Brief Assessment of Cognition in Schizophrenia (BACS)Baseline, immediate after treatment, 4-week follow upBACS is a battery of cognition tests that measure verbal memory, working memory, motor speed, verbal fluency, attention and processing speed, and executive function.The BACS is comprised of seven subtests: (1) the List Learning Test, (2) Digit Sequencing Test, (3) Token Motor Test, (4) Category Instance Test, (5) Controlled Oral Word Association Test, (6) Symbol Coding, and (7) Tower of London Test.
Change scores of 6-minute walk testBaseline, immediate after treatment, 4-week follow upThis test evaluates cardiovascular fitness and walking speed.
Change scores of 30-second chair stand testBaseline, immediate after treatment, 4-week follow upThis test evaluates muscular endurance of lower-extremities.

Secondary

MeasureTime frameDescription
Change score of Pittsburg Sleep Quality IndexBaseline, immediate after treatment, 4-week follow upPSQI is a self-report assessment which contains 19 items to measure sleep quality
Change score of Depression, Anxiety Stress Scales-21 (DASS-21)Baseline, immediate after treatment, 4-week follow upDASS-21 is a self-report questionnaire that measure symptoms of depression, anxiety, and stress.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026